Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) EBIT (2020 - 2025)

Historic EBIT for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to -$867679.0.

  • KORU Medical Systems' EBIT rose 4905.89% to -$867679.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 million, marking a year-over-year increase of 4308.58%. This contributed to the annual value of -$6.4 million for FY2024, which is 3723.23% up from last year.
  • Per KORU Medical Systems' latest filing, its EBIT stood at -$867679.0 for Q3 2025, which was up 4905.89% from -$312655.0 recorded in Q2 2025.
  • In the past 5 years, KORU Medical Systems' EBIT ranged from a high of -$312655.0 in Q2 2025 and a low of -$3.6 million during Q2 2022
  • Its 5-year average for EBIT is -$1.9 million, with a median of -$1.8 million in 2023.
  • Per our database at Business Quant, KORU Medical Systems' EBIT crashed by 47975.32% in 2021 and then soared by 7377.13% in 2025.
  • KORU Medical Systems' EBIT (Quarter) stood at -$2.1 million in 2021, then dropped by 18.85% to -$2.5 million in 2022, then increased by 12.5% to -$2.2 million in 2023, then rose by 27.67% to -$1.6 million in 2024, then soared by 45.41% to -$867679.0 in 2025.
  • Its EBIT stands at -$867679.0 for Q3 2025, versus -$312655.0 for Q2 2025 and -$1.2 million for Q1 2025.